Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care
- PMID: 17727748
- PMCID: PMC2099638
Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care
Abstract
Background: The role of procalcitonin in diagnosing bacterial infection has mainly been studied in patients with severe infections. There is no study on the value of procalcitonin measurements in adults with lower respiratory tract infection (LRTI) treated in primary care.
Aim: To evaluate the accuracy of plasma procalcitonin in predicting radiographic pneumonia, bacterial infection, and adverse outcome in a population of adults with LRTI treated in primary care.
Design of study: Prospective, observational study.
Setting: Forty-two general practices and an outpatient clinic at the Department of Infectious Diseases, Odense University Hospital, Denmark.
Method: A total of 364 patients with LRTI were prospectively enrolled from 42 general practices. Patients were examined with chest radiography, microbiological analyses, and measurements of C-reactive protein (CRP) and procalcitonin. The outcome measure was hospitalisation within 4 weeks of enrollment.
Results: Median procalcitonin was 0.05 ng/ml, which was below the functional sensitivity of the assay (0.06 ng/ml). In predicting radiographic pneumonia, bacterial infection, and hospitalisation, the sensitivities of procalcitonin >0.06 ng/ml were 0.70, 0.51, and 0.67, and of CRP were > or =20 mg/l, 0.73, 0.56, and 0.74 respectively. Corresponding positive predictive values were between 0.09 and 0.28.
Conclusion: Both procalcitonin >0.06 ng/ml and CRP > or =20 mg/l were associated with radiographic pneumonia, bacterial infection, and subsequent hospitalisation, but positive predictive values were too low for any of the two inflammatory markers to be of use in clinical practice. To measure procalcitonin values accurately in the primary care setting, a more sensitive method is needed, but there was no indication that procalcitonin is superior to CRP in identifying patients with pneumonia, bacterial aetiology, or adverse outcome.
Figures



Comment in
-
Diagnostic testing: the importance of context.Br J Gen Pract. 2007 Aug;57(541):678-9. Br J Gen Pract. 2007. PMID: 17688774 Free PMC article. No abstract available.
Similar articles
-
Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care.Br J Gen Pract. 2007 Jul;57(540):547-54. Br J Gen Pract. 2007. PMID: 17727747 Free PMC article.
-
The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.J Infect Chemother. 2014 Oct;20(10):616-20. doi: 10.1016/j.jiac.2014.06.003. Epub 2014 Jul 11. J Infect Chemother. 2014. PMID: 25027057
-
C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.Respir Care. 2014 Apr;59(4):574-81. doi: 10.4187/respcare.02741. Epub 2013 Oct 8. Respir Care. 2014. PMID: 24106319
-
What cardiologists do need to know about procalcitonin.Clin Lab. 2005;51(1-2):1-4. Clin Lab. 2005. PMID: 15719698 Review.
-
Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: clinical evidence and perspectives.Eur J Intern Med. 2011 Oct;22(5):460-5. doi: 10.1016/j.ejim.2011.02.023. Epub 2011 Mar 25. Eur J Intern Med. 2011. PMID: 21925053 Review.
Cited by
-
Predicting the presence of bacterial pathogens in the airways of primary care patients with acute cough.CMAJ. 2017 Jan 16;189(2):E50-E55. doi: 10.1503/cmaj.151364. Epub 2016 Oct 24. CMAJ. 2017. PMID: 27777252 Free PMC article.
-
Guidelines for the management of adult lower respiratory tract infections--full version.Clin Microbiol Infect. 2011 Nov;17 Suppl 6(Suppl 6):E1-59. doi: 10.1111/j.1469-0691.2011.03672.x. Clin Microbiol Infect. 2011. PMID: 21951385 Free PMC article.
-
Biomarkers: a definite plus in pneumonia.Mediators Inflamm. 2009;2009:675753. doi: 10.1155/2009/675753. Mediators Inflamm. 2009. PMID: 20011658 Free PMC article. Review.
-
The association of serum procalcitonin and high-sensitivity C-reactive protein with pneumonia in elderly multimorbid patients with respiratory symptoms: retrospective cohort study.BMC Geriatr. 2016 Jan 15;16:16. doi: 10.1186/s12877-016-0192-7. BMC Geriatr. 2016. PMID: 26772604 Free PMC article.
-
The effect of focused lung ultrasonography on antibiotic prescribing in patients with acute lower respiratory tract infections in Danish general practice: study protocol for a pragmatic randomized controlled trial (PLUS-FLUS).Trials. 2024 May 2;25(1):298. doi: 10.1186/s13063-024-08129-2. Trials. 2024. PMID: 38698471 Free PMC article.
References
-
- Raherison C, Peray P, Poirier R, et al. Management of lower respiratory tract infections by French general practitioners: the AIR II study. Analyse Infections Respiratoires. Eur Respir J. 2002;19(2):314–319. - PubMed
-
- Huchon GJ, Gialdroni-Grassi G, Leophonte P, et al. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J. 1996;9(8):1590–1595. - PubMed
-
- Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA. 1997;278(17):1440–1445. - PubMed
-
- Plouffe JF, McNally C, File TM., Jr Value of noninvasive studies in community-acquired pneumonia. Infect Dis Clin North Am. 1998;12(3):689–699. ix. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous